Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | S1PR1 | P21453 | 7/20 | 0.43 |
| ▸ | HTR2C | P28335 | 1/20 | 0.33 |
| ▸ | HTR6 | P50406 | 1/20 | 0.33 |
| ▸ | S1PR3 | Q99500 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4418394 | 0.95 | S1PR1 (0.41) | S1PR1HTR2CHTR6 | |
| SCHEMBL4331702 | 0.85 | S1PR1 (0.41) | S1PR1HTR2CHTR6 | |
| SCHEMBL11949085 | 0.84 | S1PR1 (0.59) | S1PR1S1PR3 | |
| SCHEMBL15310532 | 0.84 | S1PR1 (0.59) | S1PR1S1PR3 | |
| SCHEMBL11888782 | 0.84 | S1PR1 (0.41) | S1PR1 | |
| SCHEMBL12677724 | 0.83 | S1PR1 (0.47) | S1PR1HTR2CHTR6S1PR3 | |
| Hydrochloric Acid SCHEMBL3301047 | 0.82 | S1PR1 (0.47) | S1PR1HTR2CHTR6S1PR3 | |
| Hydrochloric Acid SCHEMBL3301053 | 0.82 | S1PR1 (0.47) | S1PR1HTR2CHTR6S1PR3 | |
| SCHEMBL4421903 | 0.81 | S1PR1 (0.48) | S1PR1HTR2CHTR6S1PR3 | |
| SCHEMBL4421912 | 0.81 | S1PR1 (0.48) | S1PR1HTR2CHTR6S1PR3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8232319-B2 | Amino phosphate derivative and S1P receptor modulator having same as an active ingredient | KYORIN PHARMACEUTICAL CO., LTD. (JP) | 2012-07-31 | — | — | US | disclosed |
| US-20090325907-A1 | AMINO PHOSPHATE DERIVATIVE AND S1P RECEPTOR MODULATOR HAVING SAME AS AN ACTIVE INGREDIENT | KYORIN PHARMACEUTICAL CO., LTD. (JP) | 2009-12-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090325907-A1 | AMINO PHOSPHATE DERIVATIVE AND S1P RECEPTOR MODULATOR HAVING SAME AS AN ACTIVE INGREDIENT | S1PR1, S1PR2, S1PR5 | S1PR1 1/4885HTR2C 779/4885HTR6 583/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.